ACSL4 antibody (C-Term)
Quick Overview for ACSL4 antibody (C-Term) (ABIN7465926)
Target
See all ACSL4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Affinity purified by Protein A.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human FACL4. The exact sequence is proprietary.
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: HeLa
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.9 mg/mL
-
Buffer
- PBS, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- ACSL4 (Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4))
-
Alternative Name
- acyl-CoA synthetase long chain family member 4
-
Background
- Acyl-CoA synthetase long chain family member 4 , ACS4 , FACL4 , LACS4 , MRX63 , MRX68,The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the mental retardation or Alport syndrome. Alternative splicing of this gene generates 2 transcript variants. [provided by RefSeq]
-
Molecular Weight
- 79 kDa
-
Gene ID
- 2182
-
UniProt
- O60488
Target
-